ATE391721T1 - Modifizierte hiv-1-peptide und ihre verwendung beim nachweisen von anti-hiv-antikörpern - Google Patents

Modifizierte hiv-1-peptide und ihre verwendung beim nachweisen von anti-hiv-antikörpern

Info

Publication number
ATE391721T1
ATE391721T1 AT05793254T AT05793254T ATE391721T1 AT E391721 T1 ATE391721 T1 AT E391721T1 AT 05793254 T AT05793254 T AT 05793254T AT 05793254 T AT05793254 T AT 05793254T AT E391721 T1 ATE391721 T1 AT E391721T1
Authority
AT
Austria
Prior art keywords
hiv
peptides
detecting anti
modified
synthetic peptide
Prior art date
Application number
AT05793254T
Other languages
English (en)
Inventor
Stephane Gadelle
Francois Rieunier
Original Assignee
Bio Rad Pasteur
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bio Rad Pasteur filed Critical Bio Rad Pasteur
Application granted granted Critical
Publication of ATE391721T1 publication Critical patent/ATE391721T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56983—Viruses
    • G01N33/56988—HIV or HTLV
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/16011—Human Immunodeficiency Virus, HIV
    • C12N2740/16111—Human Immunodeficiency Virus, HIV concerning HIV env
    • C12N2740/16122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2469/00—Immunoassays for the detection of microorganisms
    • G01N2469/20—Detection of antibodies in sample from host which are directed against antigens from microorganisms

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Virology (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Organic Chemistry (AREA)
  • Urology & Nephrology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Microbiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • Biophysics (AREA)
  • AIDS & HIV (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Food Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Peptides Or Proteins (AREA)
AT05793254T 2004-08-06 2005-07-27 Modifizierte hiv-1-peptide und ihre verwendung beim nachweisen von anti-hiv-antikörpern ATE391721T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0408733A FR2874017B1 (fr) 2004-08-06 2004-08-06 Peptides vih-1 modifies et leur utilisation en detection d'anticorps anti-vih

Publications (1)

Publication Number Publication Date
ATE391721T1 true ATE391721T1 (de) 2008-04-15

Family

ID=34948256

Family Applications (1)

Application Number Title Priority Date Filing Date
AT05793254T ATE391721T1 (de) 2004-08-06 2005-07-27 Modifizierte hiv-1-peptide und ihre verwendung beim nachweisen von anti-hiv-antikörpern

Country Status (11)

Country Link
US (1) US7988975B2 (de)
EP (1) EP1778721B1 (de)
JP (1) JP4476327B2 (de)
CN (1) CN101035804B (de)
AT (1) ATE391721T1 (de)
CA (1) CA2576715C (de)
DE (1) DE602005005999T2 (de)
ES (1) ES2302236T3 (de)
FR (1) FR2874017B1 (de)
RU (1) RU2352579C2 (de)
WO (1) WO2006024752A1 (de)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2471692A (en) * 2009-07-08 2011-01-12 Complix Nv HIV gp41-binding single-chain coiled-coil peptide comprising heptad repeats
TWI746473B (zh) * 2015-11-02 2021-11-21 美商辛分子醫藥有限公司 針對細胞內抗原之單域抗體

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4879212A (en) * 1986-04-02 1989-11-07 United Biomedical Inc. Peptide composition and method for the detection of antibodies to HTLV-III
IL88963A (en) * 1988-01-27 1996-05-14 Iaf Biochem Int Circular synthetic peptides and their mixtures for the detection of VIH antibodies and for the formation of vaccines
NZ500015A (en) * 1997-04-09 2001-06-29 Bio Rad Pasteur Synthetic peptides useful in biological assays for detecting infections caused by group O HIV-1 viruses
FR2839555B1 (fr) * 2002-05-10 2007-07-27 Bio Rad Pasteur Procede de detection simultanee d'un antigene et d'un anticorps d'un microorganisme infectieux

Also Published As

Publication number Publication date
US7988975B2 (en) 2011-08-02
US20090263785A1 (en) 2009-10-22
WO2006024752A1 (fr) 2006-03-09
CN101035804A (zh) 2007-09-12
DE602005005999T2 (de) 2009-07-23
EP1778721B1 (de) 2008-04-09
JP4476327B2 (ja) 2010-06-09
CA2576715C (fr) 2012-01-03
RU2352579C2 (ru) 2009-04-20
EP1778721A1 (de) 2007-05-02
ES2302236T3 (es) 2008-07-01
FR2874017A1 (fr) 2006-02-10
RU2007108306A (ru) 2008-09-20
JP2008509112A (ja) 2008-03-27
DE602005005999D1 (de) 2008-05-21
CA2576715A1 (fr) 2006-03-09
CN101035804B (zh) 2013-04-10
FR2874017B1 (fr) 2006-11-24

Similar Documents

Publication Publication Date Title
EA200300336A1 (ru) Пептиды вич, антигены, вакцинные композиции, набор для иммуноанализа и способ обнаружения антител, индуцируемых вич
TW200512457A (en) Method of diagnosing SARS corona virus infection
EA200100943A1 (ru) Вич-пептиды, антигены, вакцинные композиции, набор для иммуноанализа и способ определения вич-индуцированных антител
GB2438802A (en) Structure of the hepatitis C virus NS5A protein
ATE466932T1 (de) Vermehrung von viren in zellkultur
WO2004084805A3 (en) Acetylated tat polypeptides and methods of use thereof
CY1116632T1 (el) Εξουδετερωτες αντισωματων του τελεστη διεγερσης αποικιων κοκκιοκυτταρων μακροφαγων ανθρωπου
DE60233942D1 (de) Verwendung von fkbp-chaperons als expressionswerkzeug
MXPA01012662A (es) Deteccion temprana de flavivirus que utiliza la glicoproteina ns1.
DE60331677D1 (de) Kit zur untersuchung von menschlichem niedermolekulargewicht cd14 und antikörper
EA200300335A1 (ru) Регуляторные и вспомогательные пептиды вич, антигены, вакцинные композиции, набор для иммуноанализа и способ обнаружения антител, индуцируемых вич
MX2022013030A (es) Ensayos de deteccion para anticuerpos neutralizantes de coronavirus.
ATE489623T1 (de) Peptide zum nachweis von ehrlichia ewingii antikörper
ATE370160T1 (de) Peptide mit affinität zu gp120, und ihre verwendungen
DE59508137D1 (de) Spezifische bindungssubstanzen für antikörper und deren verwendung für immunoassays oder vakzine
TW200513260A (en) Hepatitis C virus derived peptides
ATE391721T1 (de) Modifizierte hiv-1-peptide und ihre verwendung beim nachweisen von anti-hiv-antikörpern
WO2003060098A3 (en) Methods for identifying compounds which inhibit binding of nucleocapsid 7 protein to hiv-1 rna
WO2010121013A3 (en) Molecularly imprinted polymers for detecting hiv-1
FR2815634B1 (fr) Anticorps monoclonaux diriges contre des virus de l'hepatite b
BR0314166B8 (pt) teste de hcv
ATE435034T1 (de) Expression und charakterisierung eines hiv-1 hüllproteins, das mit einer breitreaktiven neutralisierenden antikörperantwort assoziiert ist.
ATE359293T1 (de) Von vca-p18 kapsidantigen des epstein-barr-virus abgeleitete peptide und ihre verwendung
ATE552266T1 (de) Modifizierte hiv-1-hüllproteine
RU2000106709A (ru) Пептиды-имитаторы консервативного эпитопа белка gp41 вируса иммунодефицита человека типа 1, узнаваемого вируснейтрализующими моноклональными антителами 2f5

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties